OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment combining RU486 and Ad5IL-12 vector attenuates the growth of experimentally formed prostate tumors and induces changes in the sentinel lymph nodes of mice
Claudia Raja Gabaglia, Alexandra DeLaney, Jennifer M. Gee, et al.
Journal of Translational Medicine (2010) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Claudia Raja Gabaglia, Alexandra DeLaney, Jennifer M. Gee, et al.
Journal of Translational Medicine (2010) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Showing 13 citing articles:
Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
Masis Isikbay, Kristen Otto, Steven Kregel, et al.
Hormones and Cancer (2014) Vol. 5, Iss. 2, pp. 72-89
Open Access | Times Cited: 262
Masis Isikbay, Kristen Otto, Steven Kregel, et al.
Hormones and Cancer (2014) Vol. 5, Iss. 2, pp. 72-89
Open Access | Times Cited: 262
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
Qiuhui Li, Qu Deng, Hsueh‐Ping Chao, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 123
Qiuhui Li, Qu Deng, Hsueh‐Ping Chao, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 123
The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis
Jianzhong Chen, Jichuang Wang, Jingwei Shao, et al.
Medicinal Research Reviews (2014) Vol. 34, Iss. 5, pp. 979-1000
Closed Access | Times Cited: 86
Jianzhong Chen, Jichuang Wang, Jingwei Shao, et al.
Medicinal Research Reviews (2014) Vol. 34, Iss. 5, pp. 979-1000
Closed Access | Times Cited: 86
The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients
Zhifang Chen, Jianbing Ding, Nannan Pang, et al.
Diagnostic Pathology (2013) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Zhifang Chen, Jianbing Ding, Nannan Pang, et al.
Diagnostic Pathology (2013) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Oncolytic Adenoviruses for Cancer Immunotherapy
Vincenzo Cerullo, Anniina Koski, Markus Vähä‐Koskela, et al.
Advances in cancer research (2012), pp. 265-318
Closed Access | Times Cited: 68
Vincenzo Cerullo, Anniina Koski, Markus Vähä‐Koskela, et al.
Advances in cancer research (2012), pp. 265-318
Closed Access | Times Cited: 68
Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth
Jacob Kach, Tiha M. Long, Phillip Selman, et al.
Molecular Cancer Therapeutics (2017) Vol. 16, Iss. 8, pp. 1680-1692
Open Access | Times Cited: 47
Jacob Kach, Tiha M. Long, Phillip Selman, et al.
Molecular Cancer Therapeutics (2017) Vol. 16, Iss. 8, pp. 1680-1692
Open Access | Times Cited: 47
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
Najla Altwaijry, Sukrut Somani, John A. Parkinson, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 679-689
Open Access | Times Cited: 40
Najla Altwaijry, Sukrut Somani, John A. Parkinson, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 679-689
Open Access | Times Cited: 40
Targeted nonviral gene therapy in prostate cancer
Najla Altwaijry, Sukrut Somani, Christine Dufès
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 5753-5767
Open Access | Times Cited: 39
Najla Altwaijry, Sukrut Somani, Christine Dufès
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 5753-5767
Open Access | Times Cited: 39
Therapeutic Efficacy of Intravenously Administered Transferrin-Conjugated Dendriplexes on Prostate Carcinomas
Majed Al Robaian, Ker Yi Chiam, David R. Blatchford, et al.
Nanomedicine (2013) Vol. 9, Iss. 4, pp. 421-434
Open Access | Times Cited: 29
Majed Al Robaian, Ker Yi Chiam, David R. Blatchford, et al.
Nanomedicine (2013) Vol. 9, Iss. 4, pp. 421-434
Open Access | Times Cited: 29
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Vincenzo Cerullo, Cristian Capasso, Markus Vähä‐Koskela, et al.
Current Cancer Drug Targets (2018) Vol. 18, Iss. 2, pp. 124-138
Closed Access | Times Cited: 17
Vincenzo Cerullo, Cristian Capasso, Markus Vähä‐Koskela, et al.
Current Cancer Drug Targets (2018) Vol. 18, Iss. 2, pp. 124-138
Closed Access | Times Cited: 17
Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer
Yang Yang, Xin Li, Kenza Mamouni, et al.
Anticancer Research (2017) Vol. 37, Iss. 11
Open Access | Times Cited: 7
Yang Yang, Xin Li, Kenza Mamouni, et al.
Anticancer Research (2017) Vol. 37, Iss. 11
Open Access | Times Cited: 7
FloraStilbene: immunotherapy adjuvant for breast cancer
Famela Ramos, Santosh Kesari, George Delgado, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 45-53
Open Access
Famela Ramos, Santosh Kesari, George Delgado, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 45-53
Open Access
Sercarzian immunology – In memoriam. Eli E. Sercarz, 1934–2009
Emanual Maverakis
Cellular Immunology (2012) Vol. 273, Iss. 2, pp. 99-108
Closed Access | Times Cited: 1
Emanual Maverakis
Cellular Immunology (2012) Vol. 273, Iss. 2, pp. 99-108
Closed Access | Times Cited: 1
